Assertio Therapeutics Announces Closing of GraliseĀ® Sale to Alvogen and Expects Full-Year 2019 Neurology Franchise Net Sales Above Upper End of Prior Guidance
Stock Information for Assertio Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.